References
- History of Vitamin D. Available from: http://vitamind.ucr.edu/history.html [cited 1 October 2010].
- Unveiling the Enigma of Vitamin D. Available from: http://www.beyonddiscovery.org/content/view.txt.asp?a=414 [cited 1 October 2010].
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266–81.
- Daniel D. Bikle . Endotext website. Chapter 3 – Vitamin D: Production, metabolism, and mechanisms of action. Available from: http://www.endotext.org/parathyroid/parathyroid3/parathyroid3.htm [cited 1 October 2010].
- Nabeshima Y. Discovery of alpha-Klotho unveiled new insights into calcium and phosphate homeostasis. Proc Jpn Acad Ser B Phys Biol Sci. 2009; 85: 125–41.
- Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, et al.. Altered pharmacokinetics of 1,25-dihydroxyvitamin D3 and 25-hydroxy vitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) null mouse. Endocrinology. 2005; 146: 825–34.
- Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009; 29: 3511–36.
- Bid HK, Mishra DK, Mittal RD. Vitamin-D receptor (VDR) gene (Fok-I, Taq-I & Apa-I) polymorphisms in healthy individuals from North Indian population. Asian Pac J Cancer Prev. 2005; 6: 147–52.
- Larcombe LA, Orr PH, Lodge AM, Brown JS, Dembinski IJ, Milligan LC, et al.. Functional gene polymorphisms in Canadian aboriginal populations with high rates of tuberculosis. J Infect Dis. 2008; 198: 1175–9.
- Fleet JC. Vitamin D receptors: not just in the nucleus anymore. Nutr Rev. 1999; 57: 60–3.
- Nemere I, Schwartz Z, Pedrozo H, Sylvia VL, Dean DD, Boyan BD. Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. J Bone Miner Res. 1998; 13: 1353–9.
- Khanal R, Nemere I. Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr. 2007; 17: 31–47.
- Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol. 2008; 194: 7–17.
- Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2010; 9: 599–612.
- Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, et al.. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One. 2010; 5: e9193.
- Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010; 39: 419–46.
- Marjamäki L, Niinistö S, Kenward MG, Uusitalo L, Uusitalo U, Ovaskainen ML, et al.. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia. 2010; 53: 1599–607.
- Miller J, Gallo RL. Vitamin D and innate immunity. Dermatol Ther. 2010; 23: 13–22.
- Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007; 449: 819–26.
- Kindt TJ, Goldsby RA, Osborne BA. Innate immunity. Chapter 3 in Kuby Immunology6th ed. W.H. Freeman & Company. NY, 2007
- Bartley J. Vitamin D, innate immunity and upper respiratory tract infection. J Laryngol Otol. 2010; 13: 1–5.
- Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009; 4: 1151–65.
- Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al.. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004; 173: 2909–12.
- Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, et al.. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007; 117: 803–11.
- Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, et al.. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol. 2008; 181: 7115–20.
- Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008; 324: 23–33.
- Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain. 2009; 132: 1146–60.
- Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008; 88: 582S–586S.
- Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med. 2010; 8: 11–8.
- Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009; 57: 1595–603.
- Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 168: 1174–80.
- Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol. 2008; 52: 1949–56.
- Byers T. Anticancer vitamins du jour – The ABCED's so far. Am J Epidemiol. 2010; 172: 1–3.
- Mohr SB, Garland CF, Gorham ED, Grant WB. Could ultraviolet B irradiance and vitamin D be associated with lower incidence rates of lung cancer?. J Epidemiol Community Health. 2008; 62: 69–74.
- Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al.. The role of vitamin D in cancer prevention. Am J Public Health. 2006; 96: 252–61.
- Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, et al.. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med. 2007; 4: e103.
- Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al.. For Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006; 354: 684–96.
- Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007; 85: 1586–91.
- International Agency for Research on Cancer. (2008). Vitamin D and cancer. IARC Working Group Reports. Vol. 5. LyonFrance: International Agency for Research on Cancer. Available from: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk5/Report_VitD.pdf [cited 27 November 2010]..
- Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer. 2006; 6: 264. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665523/?tool=pubmed [cited 27 November 2010].
- Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer. 2007; 120: 1123–8.
- Tuohimaa P, Pukkala E, Scélo G, Olsen JH, Brewster DH, Hemminki K, et al.. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer. 2007; 43: 1701–12.
- Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, et al.. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 2006; 66: 10213–9.
- Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009; 69: 1439–47.
- Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, et al.. Circulating 25-hydroxyvitamin D levels and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol. 2010; 172: 81–93.
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006; 84: 18–28.
- Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001; 358: 1500–3.
- Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005; 97: 13–9.
- Brekke HK, Ludvigsson J. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr Diabetes. 2007; 8: 11–4.